news
Corona
Modern CEO: Omicron strain is expected to impair the effectiveness of vaccines
The CEO of the American Pharmaceutical Company believes that "there is no chance" that the vaccines against Corona will be as effective against the new variant as they were against the Delta variant. "All the scientists I spoke to said that 'it's not going to be good.'
Tags
Omicron variant
Modern
News agencies
Tuesday, 30 November 2021, 08:12 Updated: 08:23
Share on Facebook
Share on WhatsApp
Share on general
Share on general
Share on Twitter
Share on Email
0 comments
"I do not think there is a chance that this is the level we had against Delta," CEO Stephen Bensell said in an interview with the Financial Times today (Tuesday).
"There's going to be a drop in vaccine effectiveness, I don't know how much because we have to wait for information. But all the scientists I spoke to said, 'This is not going to be good.'"
He added that due to the large number of mutations in the virus' spike protein, the source of human infection, the current stock of vaccines may need to be updated.
In an interview with CNBC earlier, he estimated that it would take months for the delivery of effective vaccines against Omicron to begin.
Good to know (promoted)
The swimming method that will change your life (and make you fit)
To the full article
It will take months for the new vaccines to be delivered.
Modern vaccine (Photo: Reuters)
The modern CEO's remarks have heightened investor concerns around the world, as harm to vaccine effectiveness could lead to increased morbidity and prolong the global epidemic. The strain was first discovered in South Africa about a week ago, and has since caused global panic and travel restrictions. That she was being punished for her scientific abilities to identify the new variant, and called for the abolition of restrictions.
Share on Facebook
Share on WhatsApp
Share on general
Share on general
Share on Twitter
Share on Email
0 comments
